Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

The Best Stocks to Invest $1,000 in Right Now
The Best Stocks to Invest $1,000 in Right Now

What if you only had $1,000 to invest in stocks and had to put the money to work today? Which stocks would you buy? That's admittedly not an easy question to answer. I can think of lots of stocks

2 Top Stocks Down 16% and 17% This Year to Buy and Hold
2 Top Stocks Down 16% and 17% This Year to Buy and Hold

Most people love a bargain; investors do too. Purchasing shares of companies that can perform well over long periods is already pretty exciting, but it's even more so when they can be scooped up

The Best High Yield Medical Device Stock to Invest $1,000 in Right Now
The Best High Yield Medical Device Stock to Invest $1,000 in Right Now

One of the good things about the healthcare sector is that most medical care isn't optional. This is the foundation behind the sector, but on that foundation sits the growth opportunity that comes

2 High-Yield Dividend Growth Stocks to Buy Now and Hold for Decades
2 High-Yield Dividend Growth Stocks to Buy Now and Hold for Decades

If you're an income-seeking investor, a buoyant stock market near its all-time high is actually a problem. At recent prices, the average stock in the benchmark S&P 500 index offers an itty-bitty

1 Top Dividend Growth Stock to Buy Right Now
1 Top Dividend Growth Stock to Buy Right Now

Generating passive income is great for investors, and holding dividend-paying stocks is an excellent way to do that. However, not all corporations that pay dividends will be attractive to income

Palantir Technologies Has Been the S&P 500's Hottest Stock Over the Past Year, and It's Not Even Close. Can Its Incredible Rally Continue?
Palantir Technologies Has Been the S&P 500's Hottest Stock Over the Past Year, and It's Not Even Close. Can Its Incredible Rally Continue?

Palantir Technologies (NASDAQ: PLTR) is a data analytics company that leverages artificial intelligence (AI) to provide its customers with many opportunities to cut cost and add efficiency to their

1 No-Brainer Dividend Stock to Buy Now and Hold Forever
1 No-Brainer Dividend Stock to Buy Now and Hold Forever

Publicly traded corporations are under no obligation to pay dividends. Among those that do, many are rather subpar in the exercise, particularly with how often they raise their payouts. That's why

3 Underdog Stocks That Could Outperform the Market in the Second Half
3 Underdog Stocks That Could Outperform the Market in the Second Half

The stock market has been choppy in 2025, but overall by the midway point the S&P 500 index was up 5.5%. And it has recently hit a new all-time high, putting into question just how much higher it

3 Disappointing Blue Chip Stocks That Have Crashed as Much as 87% in 10 Years
3 Disappointing Blue Chip Stocks That Have Crashed as Much as 87% in 10 Years

Normally, a buy-and-hold strategy pays off, and investors expect to see strong gains from their investments. The S&P 500 (SNPINDEX: ^GSPC) has risen by 200% over the past decade, and mirroring the

3 No-Brainer Stocks to Buy in July
3 No-Brainer Stocks to Buy in July

Don't let the summer heat keep you from making money. July is a great time to invest in the stocks of top-tier companies.

Three Motley Fool contributors think they've found no-brainer stocks to buy

2 Stocks to Buy on the Dip and Hold for 10 Years
2 Stocks to Buy on the Dip and Hold for 10 Years

One of Warren Buffett's famous pieces of investing advice is to be greedy when others are fearful. One way to apply this wisdom is to look for companies that have lagged the market recently but

2 Dividend Stocks to Buy for Decades of Passive Income
2 Dividend Stocks to Buy for Decades of Passive Income

In 2013, AbbVie (NYSE: ABBV) became a publicly traded corporation after splitting from its former parent company, Abbott Laboratories (NYSE: ABT). Since then, both have produced strong returns and

2 Dividend Growth Stocks to Buy and Hold Forever
2 Dividend Growth Stocks to Buy and Hold Forever

For investors focused on the long game, there is little reason to sell -- at least, so long as a company generates solid returns through consistently improving financial results, regularly increases

2 Beaten-Down Stocks to Buy and Hold
2 Beaten-Down Stocks to Buy and Hold

Equity markets have been volatile throughout the year. We may or may not be out of the woods, but focusing on the short-term performance of stocks is not the best strategy. Regardless of what

2 Stocks to Buy With Less Than $50
2 Stocks to Buy With Less Than $50

One formula to generate strong returns on equity markets involves investing small amounts of money in top stocks regularly over long periods. Buying fractional shares is one way to apply this

Why AstraZeneca Stock Got Thumped on Thursday
Why AstraZeneca Stock Got Thumped on Thursday

AstraZeneca (NASDAQ: AZN) might soon be on the hook for an eventual 11-figure payout, and investors weren't all that comfortable with this. A Bloomberg article published Thursday morning said that

Is Pfizer Stock a Yield Trap?
Is Pfizer Stock a Yield Trap?

When it comes to your hard-earned money, you have a lot of choices about where to spend it. If your physician prescribes a new branded drug, though, you and your insurance company have few options.

Why UnitedHealth Stock Is Sinking Again Today
Why UnitedHealth Stock Is Sinking Again Today

Shares of UnitedHealth Group (NYSE: UNH) are falling today, down 4.5% as of 2:41 p.m. ET. The drop comes as the S&P 500 (SNPINDEX: ^GSPC) gained 0.3% and the Nasdaq Composite (NASDAQINDEX: ^IXIC)

Best Stocks to Buy: Hims & Hers Stock vs. UnitedHealth Stock
Best Stocks to Buy: Hims & Hers Stock vs. UnitedHealth Stock

Hims & Hers (NYSE: HIMS) and UnitedHealth (NYSE: UNH) suffered huge stock price decreases that attracted investors looking to buy the dip.

*Stock prices used were the afternoon prices of June 28

These 3 Stocks Have Been the Worst Performers in the S&P 500 This Year. Have They Bottomed Out?
These 3 Stocks Have Been the Worst Performers in the S&P 500 This Year. Have They Bottomed Out?

The threat of tariffs and trade wars sank many stocks back in April, but the market managed a sharp turnaround since then, reminiscent of the brief pandemic crash five years earlier. Many stocks are

This GLP-1 Stock's Bad News Could Be a Big Win for Eli Lilly and Novo Nordisk
This GLP-1 Stock's Bad News Could Be a Big Win for Eli Lilly and Novo Nordisk

There are a lot of healthcare companies that are investing in GLP-1 weight loss drugs. Today, the leaders in that space are Eli Lilly and Novo Nordisk. But it could get much more crowded in the

Why Amgen Stock Popped by 4% Today
Why Amgen Stock Popped by 4% Today

Following quite encouraging news from the laboratory on Monday, Amgen (NASDAQ: AMGN) was something of a stock market favorite the following day. Its shares closed the trading session more than 4%

Why AstraZeneca Stock Topped the Market on Tuesday
Why AstraZeneca Stock Topped the Market on Tuesday

Trading in AstraZeneca's (NASDAQ: AZN) American Depositary Shares (ADSes) was lively on Tuesday, on news that its leadership intends to directly list its sock on a U.S. exchange. Investors clearly

2 Dividend Stocks to Buy on the Dip and Hold Forever
2 Dividend Stocks to Buy on the Dip and Hold Forever

Over the past year, Apple (NASDAQ: AAPL) and Amgen (NASDAQ: AMGN), two well-established companies that are part of the iconic Dow Jones Industrial Average, have faced significant headwinds. Apple is

This Dirt Cheap Healthcare Stock Could Be a Hidden Artificial Intelligence (AI) Opportunity (Hint: It's Not Eli Lilly)
This Dirt Cheap Healthcare Stock Could Be a Hidden Artificial Intelligence (AI) Opportunity (Hint: It's Not Eli Lilly)

When it comes to popular healthcare stocks, investors have focused a lot of attention lately on Eli Lilly and Novo Nordisk and the potential of their blockbuster weight management treatments